5[1]DEITCH E A,MA W J,MA L,et al.Endotoxin-induced bacterial translocation:a study of mechanism[J].Surgery,1989,106:292-300.
6[2]O'REILLY M,NEWCOMB D E,REMICK D,et al.Endotoxin,sepsis,and the primrose path [J].Shock,1999,12(6):411-419.
7[3]KARIMA R.The molecular pathogenesis of endotoxic shock and organ failure[J].Mol Med Today,1999,5:123-132.
8[6]STAFF M,WEINTRAUB A,WIDALM G,et al.Structure determination of the o-antigenic polysacchanide from the enteroinvasive Escherichia coli1036[J].Eur J Biochem,1999,263(3):656-659.
9[7]RAETZ C R H.Biochemistry of endotoxins[J].Annu Rev Biochem,1990,59:129-170.
10[8]BAUMGARTNER J D,GLAUSER M P.Immunotherapy jof endotoxemia and septicemia[J].Immunobiology,1993,187:464-477.
7Igle.sias J, Marik PE, Levine JS. Norasept Ⅱ Study Investigators. Elevated serum levels of the type Ⅰ and type Ⅱ receptors for tumor necrosis factor- alpha as predictive factors for ARE in patients with septic shock. Am J Kidney Dis, 2003,41 ( 1 ): 62 - 75.
8Hu S, Sheng Z, Zhou B, et al. Study on delay two - phase multiple organ dysfuntion syndrome. Chin Med J (Engl), 1998, 111 (2) : 101 - 108.
9Thomas NJ, Umstead TM, Phelps DS. Altered ehemoldne response in an animal model of multiple organ dysfunction syndrome induced by zymosan. J Pediatr Surg,2005,40(3) :464 - 469.
10Cuzzocrea S, Mazzon E, Di Paola R, et al. A role for nitric oxide -mediated peroxynitrite formation in a model of endotoxin- induced shock. J Pharmacol Exp Ther, 2006,319 (1) : 73 - 81.
